SEBI has upheld interim restrictions on Nirman Agri Genetics and its promoter following allegations that around 93% of IPO proceeds were diverted through layered and suspect entities, while requests to resume corporate actions were rejected.
SEBI has upheld interim restrictions on Nirman Agri Genetics and its promoter following allegations that around 93% of IPO proceeds were diverted through layered and suspect entities, while requests to resume corporate actions were rejected.